Bought a few of these as the news seems to be getting better and I am sure we have now seen the bottom

ains




Maelor Approved to Hold CE Marks


Maelor plc, the AIM quoted specialist healthcare products company, is pleased to
announce that its wholly-owned subsidiary, Maelor Pharmaceuticals Limited, has
been certified to hold its own CE Marks for medical devices associated with
sterile catheter irrigation solutions.


Maelor CEO Stephen Appelbee said:


'This approval is important because it will enable us to develop and launch our
own product brands using a Maelor CE Mark. This now allows us to accelerate the
launch programme of our range of sterile catheter irrigation solutions into
several worldwide markets under our own brand. Now that we have established our
certified status it will be a straightforward process to extend this to other
devices being developed from our pipeline.


It is also formal recognition that Maelor maintains the highest quality
standards in the development and manufacture of its products

H2 on the 02/06

Ticking up a little today on mm buy - 27/28p up 6% intraday and 12.5% or so since we started a couple of weeks ago


ains

Keith

You amaze me .

B

RNS Number:2326X
Maelor PLC
25 May 2007

Maelor plc

25 May 2007



Maelor plc

(the 'Company' or 'Maelor')



Notification of Interest




The Company was notified in a letter dated 11 May 2007 that Barnard Nominees
Limited had a notifiable interest of 10,800,000 10p ordinary shares in Maelor,
being 8.69% of the issued share capital of the Company.



This announcement is in accordance with the Transparency Directive new
disclosure thresholds.

COH BLUE AGAIN

BMW325, take a look at iii on COH thread, interesting points being raised...

thanks...I will

Adieh

Very interesting...David have you any thoughts on the subject.

Im not sure that David is still with us, maybe the facilitator has taken action on here as he did on iii...

Good morning AdieH.

Yes I am still here after a chat with the faciliator who has given me the support I need to continue posting a balanced view point without the need to be insulting or to get angry with those of opposing views.

However, there is really nothing more to add on COH, simply now just let events unfold.

I believe the DTI will indeed look into to the matters I raised with them.

I continue to believe that all is not as it could be at COH.

I see the SP has fallen today despite news of buying.

I would suggest that leaving the SP talk for the company is now by far the better option.

I am more preocupied with MLR right now in any event, seeing as it is growing into a really good solid company with an excellent management team, and of course the SP is ticking up quite nicely, thank you, this week.

Do have a really nice day.

Maybe a good idea to keep both eyes on this one next week, it could motor as we get closer to the results.

Aidie

COH could well get back to 40p+ next week...have you any predictions.

Once we get confirmation of who has bought the recent placement etc then I don't see any reason why we shouldn't at least get back to 40/42p... I don't expect to see a major movement until we get more info on roll out. Kimboy on iii did some calculations and basically said for each store should add 1p to sp so based on that once we hit 90/100 stores = 1.00 and that is where I shall re-evaluate my position. Regards.

I sincerely trust they have a 100 stores, but also trust that each store makes at least the profit I indicated that any decent outfit should.

If they do that then good luck to all shareholders. If they dont they it could be a case of after the lord mayor's show etc.

Do have a really nice day and spread a smile where ever you go.

PS THIS IS THE WRONG BB MLR BEING THE TOP QUALITY SHARE THAT IT IS.

Dave the Rave...if you can post about other companies on COH, why can't we post about other companies on MLR, Ithink that is fair.

Please post away if it makes you feel better, but you are being rather ambitious coming to a quality BB.

This was a qualty BB until you appeared...LOL.

Really great post on MLR on AVFN this morning Chaps.

If they hit it big in the US of A then perhaps ten pounds a share may seem cheap.

My day gets better with each passing minute.

Such a good article that I have cut and pasted from ADVFN whom I fully acknowledge.

Maelor PLC as followers will know recent made a reverse take over of Accorus.

NEW YORK, Jan. 31 /PRNewswire-FirstCall/ -- Inyx, Inc. , a specialty pharmaceutical company focused on niche drug-delivery technologies and products, announced today that its wholly owned United Kingdom subsidiary Ashton Pharmaceuticals has been selected by Acorus Therapeutics, Ltd., a privately owned U.K.-based pharmaceutical company specializing in unique, essential medicines and medical devices, to manufacture and package a prescription-only, solid-dose product for the treatment of various forms of epilepsy and essential tremor.

Ashton is in the process of concluding process validation, method transfer and stability studies to permit commercial production of this drug to commence. Acorus and Ashton have now signed an initial three-year agreement whereby the Inyx subsidiary will be the producer of the product in a variety of dosages and packaging formats for distribution in more than 10 Western European and South American markets.

Jack Kachkar, M.D., Chairman and CEO of Inyx, Inc., said, "This contract reflects Ashton's strong solid-dose expertise, Inyx's growing packaging capabilities, and our expanding presence in global markets. We are very pleased that Ashton has been selected by Acorus Therapeutics, which is a new client for our company."

About Acorus

Acorus Therapeutics is a privately owned U.K.-based pharmaceutical company specializing in unique, essential medicines and medical devices that fulfill unmet medical needs. Acorus focuses on project management, regulatory affairs, marketing and business development, while outsourcing operations such as research, development, manufacturing and logistics. The company's corporate offices are in Hamsterley, County Durham, U.K. For more information, please visit: www.acorus-therapeutics.com.

About Inyx

ZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZ